Abstract
Chvostek’s Sign was first described in 1876, as a clinical clue associated with patients who suffered from latent tetany, and is induced by percussion of the angle of the jaw. However, over the years many clinicians have called into question the strength of the association with latent tetany, particularly in paediatric practice. This review examines the variation in techniques used to elicit the sign in studies conducted on this phenomenon in children as well as how differences in the classification of a positive Chvostek’s sign have lead to varied reports on the strength of the association. Furthermore, an appraisal of the literature regarding the proposed mechanism of Chvostek’s sign is reported alongside analysing other diseases which have been associated with Chvostek’s sign to uncover any unifying mechanism for the presence of this clinical sign in children.
Keywords: Chvostek’s sign, epilepsy, hypocalcaemia, latent tetany, migraine, pediatrics.
Current Pediatric Reviews
Title:Chvostek's Sign in Paediatric Practice
Volume: 10 Issue: 3
Author(s): Zeeshaan U. Hasan, Rania Absamara and Mas Ahmed
Affiliation:
Keywords: Chvostek’s sign, epilepsy, hypocalcaemia, latent tetany, migraine, pediatrics.
Abstract: Chvostek’s Sign was first described in 1876, as a clinical clue associated with patients who suffered from latent tetany, and is induced by percussion of the angle of the jaw. However, over the years many clinicians have called into question the strength of the association with latent tetany, particularly in paediatric practice. This review examines the variation in techniques used to elicit the sign in studies conducted on this phenomenon in children as well as how differences in the classification of a positive Chvostek’s sign have lead to varied reports on the strength of the association. Furthermore, an appraisal of the literature regarding the proposed mechanism of Chvostek’s sign is reported alongside analysing other diseases which have been associated with Chvostek’s sign to uncover any unifying mechanism for the presence of this clinical sign in children.
Export Options
About this article
Cite this article as:
Hasan U. Zeeshaan, Absamara Rania and Ahmed Mas, Chvostek's Sign in Paediatric Practice, Current Pediatric Reviews 2014; 10 (3) . https://dx.doi.org/10.2174/1573396309666131209210112
DOI https://dx.doi.org/10.2174/1573396309666131209210112 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
subject Index To Volume 2
Current Medicinal Chemistry - Central Nervous System Agents Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Central Nervous System Agents in Medicinal Chemistry Chemistry and Biological Activities of 1,3-Benzoxathiol-2-ones
Mini-Reviews in Organic Chemistry Synthesis and Anticonvulsant Activity Evaluation of 4-butyl-5-(4- alkoxyphenyl)-2H-1,2,4-triazole-3(4H)-ones
Letters in Drug Design & Discovery History Repeats Itself: Pharmacodynamic Trends in the Treatment of Anxiety Disorders
Current Pharmaceutical Design Ion Channels as Therapeutic Targets for Type 1 Diabetes Mellitus
Current Drug Targets Mechanisms and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Role of Gap Junction Channel in the Development of Beat-to-Beat Action Potential Repolarization Variability and Arrhythmias
Current Pharmaceutical Design Fetal Programming of the Human Brain: Is there a Link with Insurgence of Neurodegenerative Disorders in Adulthood?
Current Medicinal Chemistry Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities
Current Neuropharmacology Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety The Role of Histone Deacetylases in NLRP3 Inflammasomesmediated Epilepsy
Current Molecular Medicine Role of the Immune System in Autism Spectrum Disorders (ASD)
CNS & Neurological Disorders - Drug Targets Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides
Recent Patents on Drug Delivery & Formulation Neuroprotective Appraisal of Methanolic Extract of Flowers of Nerium oleander in a Non Classical Rat Model of Alzheimer Disease
The Natural Products Journal Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists
Current Medicinal Chemistry The Inhibitory Neural Circuitry as Target of Antiepileptic Drugs
Current Medicinal Chemistry Serum Thiol-Disulphide Levels in Epileptic Pediatric Patients
Combinatorial Chemistry & High Throughput Screening Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
Current Neuropharmacology Synthesis and Anticonvulsant Activity of Some Novel Semicarbazone Containing Benzoxazole: Pharmacophore Model Study
Current Bioactive Compounds